🇺🇸 FDA
Pipeline program

Enteric-Coated Mycophenolate Sodium (EC-MPS)

CERL080AKR03

Approved small_molecule completed

Quick answer

Enteric-Coated Mycophenolate Sodium (EC-MPS) for Renal Transplant is a Approved program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Novartis Pharmaceuticals
Indication
Renal Transplant
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials